Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 1/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 10/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30932003 | 0.93 | KIT (0.41) | KITMAP4K4CREBBPRETJAK2 | |
| SCHEMBL31589890 | 0.87 | CREBBP (0.44) | CREBBPNAMPTPRMT5WDR77RET | |
| SCHEMBL31589834 | 0.87 | CREBBP (0.41) | KITCREBBPRETUSP30 | |
| SCHEMBL30931972 | 0.87 | CREBBP (0.41) | KITCREBBPRETJAK2JAK1 | |
| SCHEMBL31580378 | 0.85 | CREBBP (0.40) | KITCREBBPRETJAK2JAK1 | |
| SCHEMBL31590410 | 0.84 | CREBBP (0.40) | CREBBPRETUSP30 | |
| SCHEMBL30931984 | 0.84 | CREBBP (0.43) | CREBBPPRMT5WDR77RETUSP30 | |
| SCHEMBL30932039 | 0.84 | RET (0.44) | CREBBPRETUSP30 | |
| SCHEMBL31589666 | 0.83 | JAK2 (0.41) | MAP4K4CREBBPRETJAK2JAK1 | |
| SCHEMBL30932027 | 0.82 | RET (0.46) | CREBBPRETJAK2USP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120051471-A | Novel heterocyclic compound | 首药控股(北京)股份有限公司 | 2025-05-27 | — | — | CN | disclosed |